SEC. 501. NIH INNOVATION INITIATIVES. (a) NIH Innovation Account.—
(1) IN GENERAL.—Section 1001(b) of the 21st Century Cures Act (Public Law 114–255) is amended by adding at the end the following:
“(5) SUPPLEMENTAL FUNDING AND ADDITIONAL ACTIVITIES.—
“(A) IN GENERAL.—In addition to the funds made available under paragraph (2), there are authorized to be appropriated, and are hereby appropriated, to the Account, out of any monies in the Treasury not otherwise appropriated, to be available until expended without further appropriation, the following:
“(i) For fiscal year 2022, $255,400,000.
“(ii) For fiscal year 2023, $160,400,000.
“(iii) For fiscal year 2024, $414,600,000.
“(iv) For fiscal year 2025, $547,000,000.
“(v) For fiscal year 2026, $948,000,000.
“(vi) For fiscal year 2027, $842,400,000.
“(vii) For fiscal year 2028, $1,089,600,000.
“(viii) For fiscal year 2029, $1,115,600,000.
“(ix) For fiscal year 2030, $1,170,600,000.
“(x) For fiscal year 2031, $956,400,000.
“(B) SUPPLEMENTAL FUNDING FOR CERTAIN PROJECTS.—Of the total amounts made available under subparagraph (A) for each of fiscal years 2022 through 2031, a total amount not to exceed the following shall be made available for the following categories of NIH Innovation Projects:
“(i) For projects described in paragraph (4)(A), an amount not to exceed a total of $2,070,600,000 as follows:
“(I) For each of fiscal years 2022 and 2024, $50,000,000.
“(II) For fiscal year 2025, $100,000,000.
“(III) For each of fiscal years 2026 and 2027, $300,000,000.
“(IV) For each of fiscal years 2028 through 2030, $317,000,000.
“(V) For fiscal year 2031, $319,600,000.
“(ii) For projects described in paragraph (4)(B), an amount not to exceed a total of $2,041,900,000 as follows:
“(I) For each of fiscal years 2022 and 2024, $50,000,000.
“(II) For fiscal year 2025, $128,000,000.
“(III) For fiscal year 2026, $209,000,000.
“(IV) For fiscal year 2027, $100,000,000.
“(V) For fiscal year 2028, $325,000,000.
“(VI) For fiscal year 2029, $350,000,000.
“(VII) For fiscal year 2030, $400,000,000.
“(VIII) For fiscal year 2031, $429,900,000.
“(iii) For projects described in paragraph (4)(C), an amount not to exceed a total of $1,558,400,000 as follows:
“(I) For each of fiscal years 2024 and 2025, $151,200,000.
“(II) For each of fiscal years 2026 through 2030, $251,200,000.
“(iv) For projects described in paragraph (4)(D), an amount not to exceed $15,400,000 for each of fiscal years 2022 through 2031.
“(C) ADDITIONAL NIH INNOVATION PROJECTS.—In addition to funding NIH Innovation Projects pursuant to subparagraph (B), of the total amounts made available under subparagraph (A), a total amount not to exceed the following shall be made available for the following categories of NIH Innovation Projects:
“(i) To support research related to combating antimicrobial resistance and antibiotic resistant bacteria, including research into new treatments, diagnostics, and vaccines, research, in consultation with the Centers for Disease Control and Prevention, into stewardship, and the development of strategies, in coordination with the Biomedical Advanced Research and Development Authority under section 319L of the Public Health Service Act, to support commercialization of new antibiotics, not to exceed a total of $1,144,500,000, as follows:
“(I) For each of fiscal years 2022 through 2025, $100,000,000.
“(II) For each of fiscal years 2026 and 2027, $120,000,000.
“(III) For each of fiscal years 2028 through 2030, $125,000,000.
“(IV) For fiscal year 2031, $129,500,000.
“(ii) To support research and research activities related to rare diseases or conditions, including studies or analyses that help to better understand the natural history of a rare disease or condition and translational studies related to rare diseases or conditions, not to exceed a total of $530,600,000, as follows:
“(I) For fiscal year 2022, $40,000,000.
“(II) For fiscal year 2023, $45,000,000.
“(III) For fiscal year 2024, $48,000,000.
“(IV) For each of fiscal years 2025 and 2026, $52,400,000.
“(V) For fiscal year 2027, $55,800,000.
“(VI) For fiscal year 2028, $56,000,000.
“(VII) For fiscal year 2029, $57,000,000.
“(VIII) For each of fiscal years 2030 and 2031, $62,000,000.”.
(2) CONFORMING AMENDMENTS.—Section 1001 of the 21st Century Cures Act (Public Law 114–255) is amended—
(A) in subsection (a), by striking “subsection (b)(4)” and inserting “subsections (b)(4) and (b)(5)”;